Divi's Laboratories delivered a strong beat: net profit up 64% year on year, revenue up 35% and EBITDA margin expanding roughly 1,000bps to 42.6%, pointing to robust CDMO/API demand and pricing power. As a Nifty 50 constituent, the print lends marginal support to Indian equity sentiment, but the read-through is company-specific rather than sector-wide, so broader index impact stays limited.
AI InsightAI Insight
▲ Bullish
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Divi's Laboratories' Ebitda was up 76% to Rs 1,566 crore, compared to Rs 888 crore in the year-ago period.